Blog

Discover the best analytics platform – as used by the best providers of Pharma data analytics

| Andrew Norman

For the sixth year running, Tableau – the ‘enterprise analytics platform that people love and IT trusts’ (tableau.com) is leading the way in American research and advisory firm, Gartner’s, analysis of software platforms.

Since launching our RX Analyser tool, Tableau has been our development platform of choice because it allows you to see and understand data with ease.

And, when it comes to analysing pharmaceutical data, Tableau is invaluable. We use it to offer:

RX Analyser

RX Analyser gives you the power to transform NHS and IMS prescribing data into a rich source of primary and secondary care information.

The software delivers rapid-fire, easy-to-analyse visualisations, enabling you to drill down to the key data sets you need

Salesview

Salesview enables pharmaceutical companies to understand how and where the NHS prescribes their products and their competitor’s products.

The tool provides a comprehensive analysis of the competitive prescribing landscape, giving valuable insight into product portfolios down to GP practice level.

Marketview

Marketview enables pharmaceutical companies to analyse the current prescribing of a new or potential product and help to develop a market entry strategy.

The tool provides comprehensive analysis for both NHS and pharmaceutical companies of the UK prescribing market, giving valuable insight down to CCG level.

CCGView

Our CCGView tool provides a comprehensive analysis of the detailed prescribing for an NHS CCG or LHB, down to GP practice level.

Budget Impact Models

The RXA Budget Impact Model enables pharmaceutical companies to use the NHS’s own data to produce realistic and plausible cost saving prescribing switch strategies.

Forecaster

The RXA Forecaster tool produces forecasts of the predicted sales of pharmaceutical companies’ product portfolios, based on historic prescribing trends.

With the RXA Forecaster, you can plan for the future, set sales targets and keep track of sales activity at territory and CCG levels.

Why Tableau?

With the Tableau platform, Inspiremed’s RX Analyser enables you to answer questions, share insights, and analyse data of any size, from any source, on any computing platform.

“With Tableau, our RX Analyser tool can take big data and transform it from a raw, unwieldy format into a clear, easy to read and digestible format that’s easy to interpret.”

David Warwick, Director

To find out more, contact us 01600 891594 or email info@inspire-med.co.uk

If I had to choose one feature about Rx Analyser it would be the market overview, which gives a great snapshot of the market from practice up to National level.

Sales and Marketing Manager, Leading Healthcare Company, 2016

We are working in an ever evolving industry where data increasingly drives marketing and sales activity. I believe RX Analyser is the most comprehensive analytics tool available for prescription data analysis. I can already see other business areas (within my company) that could really benefit.

Sales and Marketing Manager, Leading Healthcare Company, 2016

Key benefits? Simple graphics that are easy to use in presentations. Easy to download. And the level of available detail down to GP practice.

Senior Manager, Global Healthcare Company, 2016

Obviously I wouldn’t recommend Rx Analyser to our direct competitors as I believe the level of insight provided really gives us an edge.

Sales and Marketing Manager, Leading Healthcare Company, 2016

Comprehensive, flexible, efficient and professional. A recent training program for our sales team was both well delivered and received. Any bespoke amends to the tool are quickly implemented in line with our requirements.

Sales and Marketing Manager, Leading Healthcare Company, 2016

Our sales team use RX Analyser to analyse results and opportunity; it’s used by management to measure performance and identify national trends to drive targeting and strategy.

National Sales Manager, UK Pharmaceutical Company

Sign up for added insights